CLivD score modifies FIB-4 performance in liver fibrosis detection in the US general population
Background and aims Steatotic liver disease (SLD) is a growing global concern. The Chronic Liver Disease (CLivD) risk score predicts liver-related outcomes in the general population using easily accessible variables with or without laboratory tests (CLivDlab and CLivDnon-lab). We assessed CLivD’s as...
Saved in:
| Main Authors: | Mitja Lääperi, Fredrik Åberg, Ville Männistö |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-10-01
|
| Series: | eGastroenterology |
| Online Access: | https://egastroenterology.bmj.com/content/1/2/e100035.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Noninvasive Tests to Assess Liver Stiffness in Patients with Chronic Hepatitis B: APRI, FIB-4, and FIB-5 Scores
by: Aysun Yakut, et al.
Published: (2024-01-01) -
Comparative evaluation of APRI, FIB-4, HFS, and NFS: Scoring tools for liver fibrosis in a Mexican population with MASLD
by: B.A. Priego-Parra, et al.
Published: (2024-10-01) -
Correlation of the FIB-4 Liver Biomarker Score with the Severity of Heart Failure
by: Roxana Buzas, et al.
Published: (2024-11-01) -
Aspartate transaminase to platelet ratio index (APRI) but not FIB-5 or FIB-4 is accurate in ruling out significant fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) in an urban slum-dwelling population
by: Kailash Marotrao Kolhe, et al.
Published: (2019-08-01) -
Sequential Diagnostic Approach Using FIB-4 and ELF for Predicting Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Yeo-Wool Kang, et al.
Published: (2024-11-01)